Journal of Rehabilitation Medicine 51-4inkOmslag | Page 77

REFERENCES
1. Gracies J-M. Pathophysiology of spastic paresis. II:
emergence of muscle overactivity. Muscle Nerve 2005;
31: 552–571.
2. Lance JW. The control of muscle tone, reflexes, and mo-
vement: Robert Wartenberg Lecture. Neurology 1980;
30: 1303–1313.
3. Kellis E, Arabatzi F, Papadopoulos C. Muscle co-activation
around the knee in drop jumping using the co-contraction
index. J Electromyogr Kinesiol 2003; 13: 229–238.
4. Chae J, Yang G, Park BK, Labatia I. Muscle weakness and
cocontraction in upper limb hemiparesis: relationship to
motor impairment and physical disability. Neurorehabil
Neural Repair 2002; 16: 241–248.
5. Silva CC, Silva A, Sousa A, Pinheiro AR, Bourlinova C,
Silva A, et al. Co-activation of upper limb muscles during
reaching in post-stroke subjects: an analysis of the cont-
ralesional and ipsilesional limbs. J Electromyogr Kinesiol
2014; 24: 731–738.
6. Wissel J, Ward AB, Erztgaard P, Bensmail D, Hecht MJ,
Lejeune TM, et al. European consensus table on the use
of botulinum toxin type A in adult spasticity. J Rehabil Med
2009; 41: 13–25.
7. Yelnik AP, Simon O, Parratte B, Gracies JM. How to clinically
assess and treat muscle overactivity in spastic paresis. J
Rehabil Med 2010; 42: 801–807.
8. Marshall MM, Armstrong TJ. Observational assessment of
forceful exertion and the perceived force demands of daily
activities. J Occup Rehabil 2004; 14: 281–294.
311
9. Vinti M, Couillandre A, Hausselle J, Bayle N, Primerano A,
Merlo A, et al. Influence of effort intensity and gastroc-
nemius stretch on co-contraction and torque production
in the healthy and paretic ankle. Clin Neurophysiol 2013;
124: 528–535.
10. Sarcher A, Raison M, Ballaz L, Lemay M, Leboeuf F, Trudel
K, et al. Impact of muscle activation on ranges of motion
during active elbow movement in children with spastic
hemiplegic cerebral palsy. Clin Biomech 2015; 30: 86–94.
11. Schieber MH, Lang CE, Reilly KT, McNulty P, Sirigu A.
Selective activation of human finger muscles after stroke
or amputation. Adv Exp Med Biol 2009; 629: 559–575.
12. Hu X, Tong KY, Song R, Tsang VS, Leung PO, Li L. Variation
of muscle coactivation patterns in chronic stroke during
robot-assisted elbow training. Arch Phys Med Rehabil
2007; 88: 1022–1029.
13. Simpson DM, Gracies J-M, Graham K, Hallett M, Miyasaki
J, Naumann M, et al. Assessment: botulinum neurotoxin
for the treatment of spasticity (an evidence-based review).
Neurology 2009; 73: 736–747.
14. Foley N, Pereira S, Salter K, Fernandez MM, Speechley M,
Sequeira K, et al. Treatment with botulinum toxin impro-
ves upper-extremity function post stroke: a systematic
review and meta-analysis. Arch Phys Med Rehabil 2013;
94: 977–989.
15. Sheean G, Lannin NA, Turner-Stokes L, Rawicki B, Snow
BJ, Cerebral Palsy Institute. Botulinum toxin assessment,
intervention and after-care for upper limb hypertonicity in
adults: international consensus statement. Eur J Neurol
2010; 17: 74–93.
Spastic co-contraction and active motor impairment
J Rehabil Med 51, 2019